As ATRA and A-485 could both inhibit TRIM71 expression and glycine/serine metabolism pathway, we hypothesized ATRA combined with A-485 could attenuate liver cancer initiation and progression with TRIM71 high expression. The gene discussed is TRIM71; the disease is liver cancer.